Edition:
United Kingdom

Arcturus Therapeutics Ltd (ARCT.OQ)

ARCT.OQ on NASDAQ Stock Exchange Global Market

8.46USD
12 Dec 2017
Change (% chg)

$-0.14 (-1.63%)
Prev Close
$8.60
Open
$8.43
Day's High
$8.55
Day's Low
$8.24
Volume
11,871
Avg. Vol
24,777
52-wk High
$17.99
52-wk Low
$5.81

Chart for

About

Arcturus Therapeutics Ltd, formerly Alcobra Ltd, is an Israel-based preclinical-stage biopharmaceutical company primarily focused on the discovery, development and commercialization of ribonucleic acid (RNA) medicines using lipid-mediated nanoparticle delivery system (LUNAR) and Unlocked Nucleomonomer Agent (UNA) Oligomer... (more)

Overall

Beta: 1.47
Market Cap(Mil.): $28.94
Shares Outstanding(Mil.): 27.56
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 88.65 16.44
EPS (TTM): -- -- --
ROI: -- 2.35 10.62
ROE: -- 2.95 14.20

Earnings vs. Estimates